SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027481
Filing Date
2018-11-06
Accepted
2018-11-06 16:47:08
Documents
66
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prnb-10q_20180930.htm 10-Q 1980351
2 EX-31.1 prnb-ex311_1184.htm EX-31.1 18098
3 EX-31.2 prnb-ex312_1185.htm EX-31.2 18140
4 EX-32.1 prnb-ex321_1183.htm EX-32.1 16261
  Complete submission text file 0001564590-18-027481.txt   7312783

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prnb-20180930.xml EX-101.INS 1582821
6 XBRL TAXONOMY EXTENSION SCHEMA prnb-20180930.xsd EX-101.SCH 54147
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prnb-20180930_cal.xml EX-101.CAL 47565
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prnb-20180930_def.xml EX-101.DEF 197649
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE prnb-20180930_lab.xml EX-101.LAB 424213
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prnb-20180930_pre.xml EX-101.PRE 330135
Mailing Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 302 SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38653 | Film No.: 181163608
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1